Literature DB >> 21454716

Immunoglobulin locus associates with serum IgG levels and albuminuria.

Stacy M Herring1, Nisha Gokul, Monique Monita, Rebecca Bell, Eric Boerwinkle, Scott E Wenderfer, Michael C Braun, Peter A Doris.   

Abstract

The interaction between IgG and Fc-γ receptors in glomeruli contributes to the development of several types of proteinuric glomerular disease, but the involvement of immunological mechanisms in hypertensive renal injury is incompletely understood. Here, we investigated serum IgG levels in SHR-A3 rats, which develop hypertensive injury, and compared them with the injury-resistant SHR-B2 line. At 18 weeks old, SHR-A3 rats had serum total IgG levels nearly twice those of SHR-B2 rats, although subclass IgG2b was undetectable in SHR-A3 rats compared with mean levels (± SEM) of 80.7 ± 12.8 mg/dl (18 weeks) and 116.6 ± 19.0 mg/dl (30 weeks) in SHR-B2 rats. In addition, these two strains had significantly different serum levels of IgG1, IgG2a, and IgG2c; differences persisted at 30 weeks for all subclasses except IgG2a. Genetic mapping revealed that a locus on chromosome 6 linked to IgG subclass levels that affected IgG1, IgG2b, and IgG2c but not IgG2a. The mapped haplotype block contains IgH, suggesting regulation of three of four serum IgG subclass levels in cis. Resequencing revealed variation in the sequence of the Fc portion of the IgG heavy chain, which predicts important functional changes. To examine whether there is any relationship between this haplotype block and susceptibility to renal injury, we examined the effect of SHR-A3 and SHR-B2 alleles at this block on albumin excretion in an F2 intercross. Albuminuria doubled with inheritance of SHR-A3 alleles. In summary, allelic variation in IgH or nearby genes may modulate the susceptibility to hypertensive renal injury in SHR-A3 rats.
Copyright © 2011 by the American Society of Nephrology

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454716      PMCID: PMC3083310          DOI: 10.1681/ASN.2010111148

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  35 in total

1.  Significant differences in GM allotype frequencies between two sympatric tribes with markedly differential susceptibility to malaria.

Authors:  J P Pandey; A Nasr; K M Rocca; M Troy-Blomberg; G Elghazali
Journal:  Parasite Immunol       Date:  2007-05       Impact factor: 2.280

2.  The immunoglobulin heavy chain constant region affects kinetic and thermodynamic parameters of antibody variable region interactions with antigen.

Authors:  Marcela Torres; Narcis Fernández-Fuentes; András Fiser; Arturo Casadevall
Journal:  J Biol Chem       Date:  2007-03-12       Impact factor: 5.157

Review 3.  The immunoglobulin constant region contributes to affinity and specificity.

Authors:  Marcela Torres; Arturo Casadevall
Journal:  Trends Immunol       Date:  2008-01-10       Impact factor: 16.687

4.  Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies.

Authors:  Terrance P O'Hanlon; Lisa G Rider; Adam Schiffenbauer; Ira N Targoff; Karen Malley; Janardan P Pandey; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2008-10

5.  Fc gamma receptor-like hepatitis C virus core protein binds differentially to IgG of discordant Fc (GM) genotypes.

Authors:  Aryan M Namboodiri; Agata Budkowska; Paul J Nietert; Janardan P Pandey
Journal:  Mol Immunol       Date:  2007-05-07       Impact factor: 4.407

6.  IRF-1 gene variations influence IgE regulation and atopy.

Authors:  Michaela Schedel; Leonardo A Pinto; Bianca Schaub; Philip Rosenstiel; Dmitry Cherkasov; Lisa Cameron; Norman Klopp; Thomas Illig; Christian Vogelberg; Stephan K Weiland; Erika von Mutius; Michael Lohoff; Michael Kabesch
Journal:  Am J Respir Crit Care Med       Date:  2007-12-13       Impact factor: 21.405

7.  Hepatocyte nuclear factor 1 and hypertensive nephropathy.

Authors:  Renata I Dmitrieva; Cruz A Hinojos; Eric Boerwinkle; Michael C Braun; Myriam Fornage; Peter A Doris
Journal:  Hypertension       Date:  2008-04-28       Impact factor: 10.190

8.  Immunoglobulin allotypes influence IgG antibody responses to hepatitis C virus envelope proteins E1 and E2.

Authors:  Janardan P Pandey; Yuqun Luo; Robert C Elston; Yuping Wu; Frances Hite Philp; Jacquie Astemborski; David L Thomas; Dale M Netski
Journal:  Hum Immunol       Date:  2008-03-10       Impact factor: 2.850

9.  Exchanging murine and human immunoglobulin constant chains affects the kinetics and thermodynamics of antigen binding and chimeric antibody autoreactivity.

Authors:  Marcela Torres; Narcis Fernandez-Fuentes; András Fiser; Arturo Casadevall
Journal:  PLoS One       Date:  2007-12-12       Impact factor: 3.240

10.  Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans.

Authors:  Timothy J Aitman; Rong Dong; Timothy J Vyse; Penny J Norsworthy; Michelle D Johnson; Jennifer Smith; Jonathan Mangion; Cheri Roberton-Lowe; Amy J Marshall; Enrico Petretto; Matthew D Hodges; Gurjeet Bhangal; Sheetal G Patel; Kelly Sheehan-Rooney; Mark Duda; Paul R Cook; David J Evans; Jan Domin; Jonathan Flint; Joseph J Boyle; Charles D Pusey; H Terence Cook
Journal:  Nature       Date:  2006-02-16       Impact factor: 49.962

View more
  10 in total

1.  Hypertensive renal injury is associated with gene variation affecting immune signaling.

Authors:  Michael C Braun; Stacy M Herring; Nisha Gokul; Monique Monita; Rebecca Bell; Yaming Zhu; Manuel L Gonzalez-Garay; Scott E Wenderfer; Peter A Doris
Journal:  Circ Cardiovasc Genet       Date:  2014-11-03

2.  Susceptibility to Hypertensive Renal Disease in the Spontaneously Hypertensive Rat Is Influenced by 2 Loci Affecting Blood Pressure and Immunoglobulin Repertoire.

Authors:  Isha S Dhande; Stacy M Cranford; Yaming Zhu; Sterling C Kneedler; M John Hicks; Scott E Wenderfer; Michael C Braun; Peter A Doris
Journal:  Hypertension       Date:  2018-02-05       Impact factor: 10.190

3.  Germ-line genetic variation in the immunoglobulin heavy chain creates stroke susceptibility in the spontaneously hypertensive rat.

Authors:  Isha S Dhande; Sterling C Kneedler; Aniket S Joshi; Yaming Zhu; M John Hicks; Scott E Wenderfer; Michael C Braun; Peter A Doris
Journal:  Physiol Genomics       Date:  2019-10-14       Impact factor: 3.107

4.  Mycophenolate mofetil prevents cerebrovascular injury in stroke-prone spontaneously hypertensive rats.

Authors:  Isha S Dhande; Yaming Zhu; Michael C Braun; M John Hicks; Scott E Wenderfer; Peter A Doris
Journal:  Physiol Genomics       Date:  2016-12-23       Impact factor: 3.107

Review 5.  Mendelian and trans-generational inheritance in hypertensive renal disease.

Authors:  Michael C Braun; Peter A Doris
Journal:  Ann Med       Date:  2012-06       Impact factor: 4.709

6.  Hypertensive renal disease: susceptibility and resistance in inbred hypertensive rat lines.

Authors:  Michael C Braun; Stacy M Herring; Nisha Gokul; Monique Monita; Rebecca Bell; M John Hicks; Scott E Wenderfer; Peter A Doris
Journal:  J Hypertens       Date:  2013-10       Impact factor: 4.844

Review 7.  Genetic susceptibility to hypertensive renal disease.

Authors:  Peter A Doris
Journal:  Cell Mol Life Sci       Date:  2012-05-05       Impact factor: 9.261

8.  Stim1 Polymorphism Disrupts Immune Signaling and Creates Renal Injury in Hypertension.

Authors:  Isha S Dhande; Yaming Zhu; Sterling C Kneedler; Aniket S Joshi; M John Hicks; Scott E Wenderfer; Michael C Braun; Peter A Doris
Journal:  J Am Heart Assoc       Date:  2020-02-20       Impact factor: 5.501

Review 9.  Emerging Insights Into Chronic Renal Disease Pathogenesis in Hypertension From Human and Animal Genomic Studies.

Authors:  Isha S Dhande; Michael C Braun; Peter A Doris
Journal:  Hypertension       Date:  2021-11-10       Impact factor: 10.190

10.  Diversity in the preimmune immunoglobulin repertoire of SHR lines susceptible and resistant to end-organ injury.

Authors:  M L Gonzalez-Garay; S M Cranford; M C Braun; P A Doris
Journal:  Genes Immun       Date:  2014-07-24       Impact factor: 2.676

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.